wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34534191-1EC47FD9-89A4-4CE0-8FF5-5E11CE9B0C27
Q34534191-1EC47FD9-89A4-4CE0-8FF5-5E11CE9B0C27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34534191-1EC47FD9-89A4-4CE0-8FF5-5E11CE9B0C27
HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo
P2860
Q34534191-1EC47FD9-89A4-4CE0-8FF5-5E11CE9B0C27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34534191-1EC47FD9-89A4-4CE0-8FF5-5E11CE9B0C27
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3be794c7314510e4afc00c36c292cb1ebb6ea468
P2860
A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets.